These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

499 related articles for article (PubMed ID: 24684211)

  • 21. CNS Lyme disease manifestation in children.
    Kaciński M; Zajac A; Skowronek-Bała B; Kroczka S; Gergont A; Kubik A
    Przegl Lek; 2007; 64 Suppl 3():38-40. PubMed ID: 18431910
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral doxycycline for neuroborreliosis.
    Wormser GP; Halperin JJ
    Lancet Neurol; 2008 Aug; 7(8):665-6. PubMed ID: 18567540
    [No Abstract]   [Full Text] [Related]  

  • 23. Oral Doxycycline Compared to Intravenous Ceftriaxone in the Treatment of Lyme Neuroborreliosis: A Multicenter, Equivalence, Randomized, Open-label Trial.
    Kortela E; Kanerva MJ; Puustinen J; Hurme S; Airas L; Lauhio A; Hohenthal U; Jalava-Karvinen P; Nieminen T; Finnilä T; Häggblom T; Pietikäinen A; Koivisto M; Vilhonen J; Marttila-Vaara M; Hytönen J; Oksi J
    Clin Infect Dis; 2021 Apr; 72(8):1323-1331. PubMed ID: 32133487
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Practice parameter: treatment of nervous system Lyme disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.
    Halperin JJ; Shapiro ED; Logigian E; Belman AL; Dotevall L; Wormser GP; Krupp L; Gronseth G; Bever CT;
    Neurology; 2007 Jul; 69(1):91-102. PubMed ID: 17522387
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lyme neuroborreliosis in children: a prospective study of clinical features, prognosis, and outcome.
    Skogman BH; Croner S; Nordwall M; Eknefelt M; Ernerudh J; Forsberg P
    Pediatr Infect Dis J; 2008 Dec; 27(12):1089-94. PubMed ID: 19008771
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Neuroborreliosis - Diagnostics, treatment and course].
    Dersch R; Rauer S
    Nervenarzt; 2017 Apr; 88(4):419-431. PubMed ID: 28175945
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Should Lyme disease affecting the nervous system be treated with oral or intravenous antibiotics?
    Selby G; Bridges SJ; Hanington L
    Arch Dis Child Educ Pract Ed; 2008 Aug; 93(4):132-4. PubMed ID: 18644904
    [No Abstract]   [Full Text] [Related]  

  • 28. Lyme neuroborreliosis: a treatable cause of acute ocular motor disturbances in children.
    Correll MH; Datta N; Arvidsson HS; Melsom HA; Thielberg AK; Bjerager M; Brodsky MC; Saunte JP
    Br J Ophthalmol; 2015 Oct; 99(10):1401-4. PubMed ID: 25868792
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lyme neuroborreliosis and dementia.
    Blanc F; Philippi N; Cretin B; Kleitz C; Berly L; Jung B; Kremer S; Namer IJ; Sellal F; Jaulhac B; de Seze J
    J Alzheimers Dis; 2014; 41(4):1087-93. PubMed ID: 24762944
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cerebrovascular Events in Lyme Neuroborreliosis.
    Wittwer B; Pelletier S; Ducrocq X; Maillard L; Mione G; Richard S
    J Stroke Cerebrovasc Dis; 2015 Jul; 24(7):1671-8. PubMed ID: 26002071
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adverse effects of minocycline versus doxycycline in the treatment of Lyme neuroborreliosis.
    Dotevall L; Hagberg L
    Clin Infect Dis; 2000 Feb; 30(2):410-1. PubMed ID: 10671363
    [No Abstract]   [Full Text] [Related]  

  • 32. Comparison of intravenous penicillin G and oral doxycycline for treatment of Lyme neuroborreliosis.
    Karlsson M; Hammers-Berggren S; Lindquist L; Stiernstedt G; Svenungsson B
    Neurology; 1994 Jul; 44(7):1203-7. PubMed ID: 8035916
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lyme neuroborreliosis-associated cerebrovascular events in the Finnish endemic area.
    Mironova M; Kortela E; Kurkela S; Kanerva M; Curtze S
    J Neurol Sci; 2021 Aug; 427():117544. PubMed ID: 34153843
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Neuroboreliosis with motoric disturbations in the developmental age].
    Skowronek-Bała B; Wesołowska E; Gergont A; Kaciński M
    Przegl Lek; 2008; 65(11):810-2. PubMed ID: 19205367
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oral doxycycline versus intravenous ceftriaxone for treatment of multiple erythema migrans: an open-label alternate-treatment observational trial.
    Stupica D; Velušcek M; Blagus R; Bogovic P; Rojko T; Cerar T; Strle F
    J Antimicrob Chemother; 2018 May; 73(5):1352-1358. PubMed ID: 29385444
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Successful oral doxycycline treatment of Lyme disease-associated facial palsy and meningitis.
    Dotevall L; Hagberg L
    Clin Infect Dis; 1999 Mar; 28(3):569-74. PubMed ID: 10194080
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Epidemiology and therapy of Lyme arthritis and other manifestations of Lyme borreliosis in Germany: results of a nation-wide survey].
    Priem S; Munkelt K; Franz JK; Schneider U; Werner T; Burmester GR; Krause A
    Z Rheumatol; 2003 Oct; 62(5):450-8. PubMed ID: 14579032
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Neuroborreliosis--a disease with many faces].
    Czell D; Rodic B; Imoberdorf R
    Praxis (Bern 1994); 2011 May; 100(10):607-12. PubMed ID: 21563099
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Occurrence of erythema migrans in children with Lyme neuroborreliosis and the association with clinical characteristics and outcome - a prospective cohort study.
    Backman K; Skogman BH
    BMC Pediatr; 2018 Jun; 18(1):189. PubMed ID: 29890951
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical manifestations and long-term outcome of early Lyme neuroborreliosis according to the European Federation of Neurological Societies diagnostic criteria (definite versus possible) in central Europe. A retrospective cohort study.
    Stupica D; Bajrović FF; Blagus R; Cerar Kišek T; Collinet-Adler S; Lah A; Levstek E; Ružić-Sabljić E
    Eur J Neurol; 2021 Sep; 28(9):3155-3166. PubMed ID: 34114701
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.